Brain ageing: using neuroimaging to understand risk for and resilience against dementia
Brain imaging plays an increasingly important role in experimental medicine for dementia by providing biomarkers for diagnosis, prognosis, patient stratification and monitoring treatment response. Imaging can also provide insights into mechanisms of risk and resilience for neurodegeneration. The Translational Neuroimaging Group investigate brain ageing in both health and disease. We have demonstrated that people at increased risk of later developing Alzheimer’s and Parkinson’s disease have particular ‘signatures’ of brain activity. I will introduce some of the methodology and describe how the techniques are being used to improve our understanding of brain ageing.
Date:
27 April 2017, 14:00 (Thursday, 1st week, Trinity 2017)
Venue:
66 Banbury Road (Wolsey Hall), 66 Banbury Road OX2 6PR
Venue Details:
Seminar Room
Speaker:
Professor Clare Mackay (Associate Professor of Psychiatry and Senior Research Fellow, University of Oxford)
Organising department:
Oxford Institute of Ageing
Organiser contact email address:
administrator@ageing.ox.ac.uk
Host:
Dr Sara Zella (University of Oxford)
Part of:
Ageing, Wellbeing and Health
Booking required?:
Not required
Audience:
Public
Editor:
Katia Padvalkava
